申请人:Senju Pharmaceutical Co., Ltd.
公开号:EP3998262A1
公开(公告)日:2022-05-18
A compound having Nrf2-activating action is provided. The compound is represented by formula (I), a salt of the compound, or a solvate of the compound or salt:
wherein R1a and R1b are identical or different and represent a hydrogen atom, an alkyl group, or a halogen atom; R2 represents an optionally substituted group derived from a heterocycle, and the heterocycle represents thiophene, furan, pyrrole, thiazole, or a fused ring including any of these heterocycles; R4 and R5 are identical or different and represent a hydrogen atom or an optionally substituted alkyl group, or R4 and R5 bind with each other to form -NH-CH=N-; R6 represents an optionally substituted alkyl group; A1, A2, A3, and A4 are identical or different and represent CH or N wherein the number of N is 1 or less; and Z represents a hydrogen atom or a halogen atom.
提供了一种具有 Nrf2 激活作用的化合物。该化合物由式(I)、该化合物的盐或该化合物或盐的溶液表示:
其中 R1a 和 R1b 相同或不同,代表氢原子、烷基或卤素原子;R2 代表衍生自杂环的任选取代基团,杂环代表噻吩、呋喃、吡咯、噻唑或包括上述任何杂环的融合环;R4 和 R5 相同或不同,代表氢原子或任选取代的烷基,或 R4 和 R5 相互结合形成 -NH-CH=N-;R6 代表任选取代的烷基;A1、A2、A3 和 A4 相同或不同,代表 CH 或 N,其中 N 的数目为 1 或更少;Z 代表氢原子或卤素原子。